Osteoporosis Market Research Reports & Industry Analysis
Osteoporosis is characterized by decreased bone mineral density (BMD) and deterioration of the bone microarchitecture, a combination of factors that lead to an increased risk of fracture. Osteoporosis affects hundreds of millions of people worldwide, in developed and undeveloped nations. The prevalence of osteoporosis is projected to increase considerably as the global population ages and life expectancy increases as anticipated. The Office of the Surgeon General in the U.S. warns that osteoporosis may become an epidemic if people do not make the adjustments in nutrition, supplementation, and physical activity necessary to prevent osteoporosis.
The overall cost of osteoporosis fractures and their complications poses a considerable burden for healthcare systems around the world; osteoporosis costs are comparable with those of other major chronic diseases, such as cardiovascular diseases and asthma. In addition, osteoporosis fractures are a major cause of disability and morbidity among older people; an estimated fifth of patients who experience an osteoporotic hip fracture die due to complications within 1 year after the fracture. Drug therapies that are capable of addressing osteoporosis and reducing the risk of fractures could bring economic benefits to governments and healthcare providers and improve the quality of life for osteoporosis patients.
Osteoporosis Industry Research & Market Reports
-
Global Osteoporosis Drugs Market Report by Route of Administration (Injectable, Oral, Others) Product Type (Rank Ligand Inhibitor, Bisphosphonates, Calcitonin, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Sclerostin Inhibitor, Others) Countries and Company Analysis, 2024-2032
... 2024-2032 Osteoporosis Drugs Market Analysis The osteoporosis drugs market is expected to over US$ 25.53 billion by 2032 from US$ 17.43 billion by 2023, with a CAGR growth of 4.33% from 2024 to 2032 because ... Read More
-
Osteoporosis: Seven-Market Drug Forecast and Market Analysis
... as a systemic skeletal disease characterized by low bone mass and micro-architectural deterioration of bone tissue, predisposing a person to bone fragility and susceptibility to fracture. Common sites of fracture include the spine, hip, distal ... Read More
-
Bone Densitometers Market Assessment, By Type [Central Scan, Peripheral Scan], By Application [Cystic Fibrosis, Chronic Kidney Disease, Osteopenia & Osteoporosis, Body Composition Measurement, Rheumatoid Arthritis], By Technology [Single X-ray Absorptiometry, Dual Energy X-ray Absorptiometry, Quantitative Computed Tomography, Others], By End-user [Hospitals & Clinics, Diagnostic Centers, Academic and Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F
... Computed Tomography, Others], By End-user [Hospitals & Clinics, Diagnostic Centers, Academic and Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F Global bone densitometers market is projected to witness a CAGR of 3.9% during the ... Read More
-
Post Menopausal Osteoporosis – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Post Menopausal Osteoporosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Post Menopausal Osteoporosis market report provides current ... Read More
-
Erosive Hand Osteoarthritis – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Erosive Hand Osteoarthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Erosive Hand Osteoarthritis market report provides current ... Read More
-
United States Women’s Health Market By Drug (ACTONEL, YAZ, Yasmin, Yasminelle, FORTEO, Minastrin 24 Fe, Mirena, NuvaRing, ORTHO TRI-CY LO, Premarin, Prolia, Reclast/Aclasta, XGEVA, Zometa, Others), By Application (Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Region and Competition, Opportunity, and Forecast, 2019-2029F
... Uterine Fibroids, Menopause, Polycystic Ovary Syndrome), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Region and Competition, Opportunity, and Forecast, 2019-2029F United States Women’s Health Market was valued at USD 19.78 billion in 2023 ... Read More
-
Osteoporosis: Epidemiology Forecast to 2033
... dissolve (resorption) and new bone cells grow back (formation). For people with osteoporosis, bone loss outpaces the growth of new bone. Consequently, bones become more porous and fragile, leading to weakness of the skeleton and ... Read More
-
Women's Healthcare Market Size, Trends, Analysis, and Outlook By Drug (XGEVA, Mirena, EVISTA, Prolia, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, Premarin, FORTEO, ACTONEL, Others), By Application (Postmenopausal Osteoporosis, Menopause, Endometriosis, Hormonal Infertility, Contraceptives, Others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online providers), by Country, Segment, and Companies, 2024-2032
... Distribution Channel (Hospital pharmacies, Retail pharmacies, Online providers), by Country, Segment, and Companies, 2024-2032 The global Women's Healthcare market size is poised to register 5.3% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
Orthobiologics Market Size, Trends, Analysis, and Outlook By Product (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Others), By Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-tissue Injuries, Others), By End-User (Hospitals, Orthopedic Clinics, Ambulatory Care Centers, Research and Academic Institutes, Dental Clinics and Facilities), by Country, Segment, and Companies, 2024-2032
... Orthopedic Clinics, Ambulatory Care Centers, Research and Academic Institutes, Dental Clinics and Facilities), by Country, Segment, and Companies, 2024-2032 The global Orthobiologics market size is poised to register 5.9% growth from 2024 to 2032, presenting ... Read More
-
Osteoarthritis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 4.74% during the forecast period (2024-2029). The COVID-19 pandemic had a short-term impact on the market growth as it led to the cancelation or postponement of the ... Read More
-
Women's Health Diagnostics Market Report by Type (Diagnostic Devices, Diagnostic Tests), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing, and Others), End User (Hospital and Diagnostics Centers, Home Care), and Region 2024-2032
... Home Care), and Region 2024-2032 The global women's health diagnostics market size reached US$ 29.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 52.6 Billion by 2032, exhibiting a growth ... Read More
-
Osteoarthritis - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Osteoarthritis Understanding ... Read More
-
Erosive Hand Osteoarthritis - Pipeline Insight, 2024
... Osteoarthritis market. A detailed picture of the Erosive Hand Osteoarthritis pipeline landscape is provided, which includes the disease overview and Erosive Hand Osteoarthritis treatment guidelines. The assessment part of the report embraces in-depth Erosive Hand ... Read More
-
Knee osteoarthritis – Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Global Viscosupplementation for Knee Osteoarthritis Market Growth 2024-2030
... in downstream market, the Viscosupplementation for Knee Osteoarthritis is forecast to a readjusted size of US$ 2304 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential ... Read More
-
Viscosupplementation Market, By Dosage (Single Injection, Three Injection, and Five Injection), By Arthritis Type (Osteoarthritis and Rheumatoid Arthritis), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Europe, Asia Pacific, Middle East & Africa) Viscosupplementation is an orthopedic treatment method used to manage osteoarthritis knee pain. It involves injecting hyaluronic acid, also known as hyaluronan, into the knee joint. Hyaluronic acid acts ... Read More
-
Anti-Osteoporosis Therapy and Fracture Healing Market Size, Trends, Analysis, and Outlook By Drug (Bi-phosphates, Calcitonin, Estrogen or Hormone Replacement Therapy, Others), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacy, Drug Stores, Retail Pharmacy, E-commerce), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacy, E-commerce), by Region, Country, Segment, and Companies, 2024-2030 The global Anti-Osteoporosis Therapy and Fracture Healing market size is poised to register 8.71% growth from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Geriatric Medicine Market Size, Trends, Analysis, and Outlook By Therapeutics (Analgesic, Antihypertensive, Statins, Antidiabetic, PPI, Anticoagulant, Antipsychotic, Others), By Condition (Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory , Others), by Region, Country, Segment, and Companies, 2024-2030
... The global Geriatric Medicine market size is poised to register 7.74% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Geriatric Medicine market ... Read More
-
Viscosupplementation Market Size, Trends, Analysis, and Outlook By Product (Single, Three, Five Injection), By Application (Knee, Hip Osteoarthritis), By Source (Animal, Non-Animal), By End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global Viscosupplementation market size is poised to register 10.39% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Viscosupplementation market ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoporosis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Bisphosphonates
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Osteoporosis Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Musculoskeletal Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
Research Assistance
